(
216
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Advances in allergen immunotherapy I
-
Advances in understanding allergen immunotherapy, drug and food allergy
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
Bronchial allergen challenge in research
-
Bronchial allergen challenge in the clinic
-
Cutting edge allergen immunotherapy
-
Flash Talks on allergen immunotherapy
-
Flash talks on allergen Immunotherapy I
-
Food allergen ladders: a need for standardization
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Improving patient care with allergen immunotherapy (AIT): Lessons learned from randomised control trials (RCT) and real world evidence (RWE) studies
-
Nasal allergen challenge
-
New Perspectives on Allergen Immunotherapy
-
New Perspectives on Allergen Immunotherapy
-
Next generation vaccinology and allergen immunotherapy: from mechanisms to practice
-
Practical recommendations on allergen AiT
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Safety and prediction of allergen immunotherapy
-
Standardisation of Allergen Immunotherapy products and Legal Considerations
Show more Event Resources (17)Show Less-
-
Allergen immunotherapy for respiratory allergy: quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs
-
Allergen immunotherapy: The growing role of observational and randomized trial “Real-World Evidence”
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy
-
Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper
-
EAACI Position paper on the standardization of nasal allergen challenges
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
-
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
-
Placebo effects in allergen immunotherapy – An EAACI Task Force Position Paper
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
-
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
-
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
-
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
-
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies – Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology task force
Show more Position Papers (15)Show Less-
-
Allergen Immunotherapy and Biologicals
-
Allergen immunotherapy and co-evaluation of COVID-19 vaccines
-
Eosinophilic esophagitis and allergen immunotherapy
-
Food Allergen Thresholds
-
Health economics of allergen immunotherapy
-
Nocebo effect of allergen immunotherapy
-
WHO-IUIS Allergen Nomenclature Committee
Show more Task Forces (5)Show Less-
-
Allergen composition of preparations translate into clinical outcomes of AIT
-
Allergen immunotherapy with allergoid-mannan conjugates: from basic science to clinical research
-
Changing the way babies eat: Supporting early allergen feeding around the world
-
Patients’ perspective : a must have for the future of Allergen Immunotherapy
-
Updates on molecular allergology & food allergen components
Show more Sponsored Symposia (3)Show Less-
-
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
-
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
-
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy
-
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
-
EAACI guidelines on allergen immunotherapy: Prevention of allergy
Show more Guidelines (3)Show Less-
-
Digitally-enabled, person-centred care (PCC) in allergen immunotherapy: An ARIA-EAACI Position Paper
-
Evaluation of clinical outcomes of efficacy in food allergen immunotherapy trials, COFAITH EAACI task force
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
Show more Consensus Documents (1)Show Less-
Website
Collapse
-
A positive conjunctival allergen challenge is more common in allergic rhinitis patients with conjunctivitis than in local allergic rhinitis individuals with conjunctivitis
-
A positive conjunctival allergen challenge is more common in allergic rhinitis patients with conjunctivitis than in local allergic rhinitis individuals with conjunctivitis
-
A study to assess the impact of allergy on a subject’s sense of smell when exposed to allergen in an Environmental Exposure Chamber (EEC)
-
A study to assess the impact of nasal congestion on a subject’s perception of facial and head discomfort when exposed to allergen in an Environmental Exposure Chamber (EEC)
-
Advances in Allergen Immunotherapy
-
Advances in Allergen Immunotherapy (AIT)
-
Age-related fungal molecular clusters revealed by allergen multiplex in Southern France
-
Age-related fungal molecular clusters revealed by allergen multiplex in Southern France
-
Allergen Immunotherapy
-
Allergen Immunotherapy
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)
-
Allergen Immunotherapy for the prevention of respiratory allergy
-
Allergen Immunotherapy in the Republic of Kazakhstan
-
Allergen identification in an emerging predatory mite, Cheyletus eruditus. Cross-reactive analysis with other mite allergens
-
Allergen identification in an emerging predatory mite, Cheyletus eruditus. Cross-reactive analysis with other mite allergens
-
Allergen immunotherapy
-
Allergen immunotherapy (AIT) in pregnancy, focus on the use of carbamylated monomeric allergoid
-
Allergen immunotherapy 1
-
Allergen immunotherapy 2
-
Allergen immunotherapy 3
-
Allergen immunotherapy 4
-
Allergen immunotherapy 5
-
Allergen immunotherapy 6
-
Allergen immunotherapy 7
-
Allergen immunotherapy in food allergy, what’s new?
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergen immunotherapy – Basic and clinical perspective
-
Allergen immunotherapy/Biologicals
-
Allergen interactions in the innate system vs. the adaptive system
-
Allergen metabolism by human oral bacteria alters its allergenicity
-
Allergen protein families: uses and pitfalls
-
Allergen specific IgE is a stronger predictor of remission following Peanut Oral Immunotherapy in children aged 1-10 years
-
Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander
-
Analysis of epinephrine use during peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1 to 3 years
-
Analyzing Factors Influencing Adherence to Classify Adherence Levels in Patients Treated with Allergen Immunotherapy
-
Application of allergen standardization in allergen-specific immunotherapy (AIT)
-
Applying allergen threshold to dietary management of food allergy
-
Artificial intelligence and precision immunology: pioneering biomarker discovery in allergen immunotherapy
-
Assessing specific pro-catabolic mediators (SPMs) as Innovative Biomarkers in Allergen Immunotherapy: Monitoring Treatment Efficacy
-
Asthma phenotype markers did not affect allergen immunotherapy effectiveness
-
Basophil allergen threshold sensitivity to casein in milk allergic patients
-
Birch Rust: Unveiling a Novel Fungal Allergen in Seasonal Airway Allergy Symptoms – Insights from the First Clinical Cohort in Northern Norway
-
Can symptoms in Alternaria allergy be linked with objective diagnostic criteria? From intranasal allergen challenge to IgE and basophil activation test
-
Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science
-
Comparing intrinsic sensitizing capacity of cow’s milk allergens β-lactoglobulin and αs-casein with hen’s egg allergen ovalbumin in an in vitro co-culture model using human epithelial and dendritic cells
-
Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort
-
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: PATIENT’S RESULTS
-
Criteria used by health professionals on the selection of allergen immunotherapy in real clinical practice. CHOICE project results from Interim analysis 2023: DOCTOR’S RESULTS
-
Cryptomeria as a novel allergen impacts tree pollen sensitization in Ukraine
-
DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy
-
Delving deeper in allergen immunotherapy
-
Development and implementation of an intelligence platform for management of allergen immunotherapy in China
-
Development of a thermosensitive poloxamer formulation designed to provide a controlled release of the active pharmaceutical ingredient in birch pollen allergen immunotherapy
-
Development of monoclonal antibodies against dog allergens and their application for the analysis of dog allergen extracts
-
Development, characterization and application of aptamers for the detection and quantification of the major peanut allergen Ara h 1
-
Discovering new horizons in allergen immunotherapy
-
Diverse IgE reactivity profiles in patients undergoing allergen immunotherapy, the reflection of regional sensitization – pilot study
-
Does the Ratio between Allergen and Histamine Wheal Surface-Areas Correlate with the Detection of Specific IgE by a Microarray Platform?
-
Early inflammatory reactions in mice after immunotherapy with an allergen microcrystalline tyrosine adsorbate
-
Effect of allergen – specific immunotherapy on PFS symptoms
-
Effect of allergen specific immunotherapy on PFS symptoms
-
Effect of allergen specific immunotherapy on PFS symptoms
-
Evidence of kinetic proofreading through allergen specific IgE at the human mast cell IgE receptor
-
Evolving the Allergen Encyclopedia – A Comprehensive and Intuitive Educational Resource
-
Exposure-adjusted safety of peanut (Arachis hypogaea) allergen powder-dnfp oral immunotherapy in individuals with peanut allergy aged 1-3 years (POSEIDON trial)
-
False positives in sIgE to Xip g 1 using a commercial allergen microarray related to polcalcin sensitization
-
False positives in sIgE to Xip g 1 using a commercial allergen microarray related to polcalcin sensitization
-
Flash talks on Allergen Immunotherapy 1
-
Flash talks on Allergen Immunotherapy 2
-
Flash talks on Allergen Immunotherapy 3
-
Flash talks on Allergen Immunotherapy 4
-
Food Protein Standards with Defined Allergen Composition for Use as Reference Materials
-
Food allergen epitopes steering food allergy diagnostics
-
Frontiers in Allergen Immunotherapy: evidence from clinical trials
-
Generation and preclinical characterization of birch pollen allergen Bet v 1 conjugated with a TLR7 activator
-
Harmonizing clinical outcomes in food allergen immunotherapy: COFAITH EAACI Taskforce
-
High resolution structure of a human IgE mAb epitope on major cat allergen Fel d 1
-
How allergists around the world perceive innovation in the context of allergen Immunotherapy AIT: an international survey
-
ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy
-
Identification of IgE-binding epitopes in the peach allergen R-mandelonitrile lyase
-
Identification of gibberellin-regulated protein as a new allergen in strawberry allergy
-
IgE-sensitisation profile to peanut allergen components: reassessment of the prevalence and patterns on a global scale
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
Impact of Security Measures Implementation in Subcutaneous Allergen Immunotherapy Administration at a Pediatric Hospital in Mexico
-
Impact of reaction conditions on surface modification of glass microtiter wells used in development of allergen microarrays
-
Inhalant allergen panel- a single center 6-year experience
-
Intestinal-restricted location of allergen-specific regulatory T cells is driven by oral consumption of the allergen in murine models
-
Intestinal-restricted location of allergen-specific regulatory T cells is driven by oral consumption of the allergen in murine models
-
Intralymphatic immunotherapy with aluminium hydroxide based grass allergen reduced medication use in patients with allergic rhinoconjunctivitis: a double-blind randomized placebo-controlled trial
-
Liquid Handling Robotics for Improved Standardization of ELISA Kits for Allergen Detection
-
Local allergic rhinitis in paediatric patients: prevalence and clinical outcomes in nasal allergen challenge
-
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
-
Measurement of serum specific IgE to Ryegrass allergen component Lol p 5 in the TAISAR cohort predicts risk of Thunderstorm Asthma
-
Microneedles-based transdermal allergen specific immunotherapy protects against gliadin induced anaphylaxis in a mouse model
-
Modified Peanut Allergen mRNA Induces Cross-Blocking Antibodies that Protect Against Allergic Reactions in an in-vivo Allergy Model
-
Modulation of B cell memory responses by house dust mite allergen immunotherapy
-
Molecular Allergen Sensitization Disparities in a Turkish Population: A Comprehensive Interregional Analysis
-
Molecular Allergen Sensitization Disparities in a Turkish Population: A Comprehensive Interregional Analysis
-
Molecular allergen diagnosis
-
Molecular allergen sensitizations drive phenotypes of severe asthma in children: evidence from a megacity cohort (SAMP)
-
Molecular approach to the allergen exposome amongst Mediterranean children
-
Monocyte chemotactic factors in the airways of patients with asthma after an allergen challenge
-
Nasal Allergen Challenges in the clinical setting: Experience of a centre
-
New allergens approved by the WHO/IUIS Allergen Nomenclature Sub-Committee in 2021-2023
-
Oral immunotherapy decreases expression of pro-inflammatory genes upon re-exposure to allergen in egg allergic children
-
Oxidative Balance In Exhaled Breath Condensate In Patients With Allergic Rhinitis: The Effect Of Diet And Allergen Exposure On Oxidative Stress
-
Patient preference: A multinational discrete-choice-experiment (DCE) in pollen allergen immunotherapy (AIT)
-
Peanut Lectin: Why It Is Not a Major Peanut Allergen
-
Peanut and tree nut allergen components around the corner – for potential future use in the clinic?
-
Poloxamer formulation for allergen immunotherapy reduces systemic allergic reactions in a mouse model
-
Polyclonal desensitization impairs mast cell responses in an allergen specific manner without compromising IgE signaling ability
-
Polyclonal desensitization impairs mast cell responses in an allergen specific manner without compromising IgE signaling ability
-
Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system
-
Pre-treating allergic rhinitis sufferers with fexofenadine before allergen exposure
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
Prospective, pilot, phase 1 study of iPUMP© in patients starting sublingual allergen immunotherapy (Staloral©)
-
Real world data on persistence and compliance with sublingual allergen specific immunotherapy, a Dutch experience
-
Real-world study: safety and effectiveness of a subcutaneous glutaraldehyde, polymerized undiluted D.pteronyssinus-D.farinae allergen extract
-
Real-world study: safety and effectiveness of a subcutaneous glutaraldehyde, polymerized undiluted olive-grasses allergen extract
-
Real-world study: safety and effectiveness of a subcutaneous glutaraldehyde, polymerized undiluted olive-grasses allergen extract
-
Recombinantly made allergen panel for the evaluation of nsLTP cross-reactivity profiles in patients
-
Reduced allergenicity of the mold major allergen Alt a 1 when iron is sufficient: implications in nutritional immunity and immune resilience
-
Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy
-
Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review
-
Sensitization to common pets’ allergen components in children
-
Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis
-
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens
-
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in pediatric patients with allergic rhinitis due to house dust mites or pollens
-
Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis
-
Systemic allergic reactions to subcutaneous allergen immunotherapy – A single center experience
-
TAPAS – a long-term non-interventional study evaluating MCT (MicroCrystalline Tyrosine)-associated allergoids shows non-inferiority of clinical effectiveness in children compared to adults during a 3-year course of allergen immunotherapy
-
The Distribution of Allergen Sensitization and Screening Panel for Respiratory Allergic Diseases in Seven Geographical Regions of China: A multicenter study
-
The Quest for Tolerance in Allergen Immunotherapy
-
The cross-protective activity of allergen immunotherapy-induced blocking antibodies accords with the structural identity of allergens
-
The cross-protective activity of allergen immunotherapy-induced blocking antibodies accords with the structural identity of allergens
-
The cross-protective activity of allergen immunotherapy-induced blocking antibodies accords with the structural identity of allergens
-
The definition of the standardization unit of cat allergen extracts and its impact on their potency
-
The journey to registration: challenges for allergen immunotherapy trials
-
Therapeutic efficacy of a biodegradable microneedle patch loaded with peanut allergen in a peanut allergy model
-
Timothy Grass Aerosolization in Novel Allergen Exposure Chamber
-
Towards an artificial intelligence-assisted allergy diagnosis using semantic attributes and allergen multiplex technology
-
Two decades of Allergen Sensitivity: Insights from Prick Test Data in a Chilean Allergic Center
-
Unmasking Mite Anaphylaxis – a Hidden Oral Allergen
-
Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy
-
Utility of conjunctival allergen challenge in the diagnosis of patients with different phenotypes of allergic rhinitis and conjunctival symptoms
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
“Rhythm of Success”: Sustaining Benefits in Allergen Immunotherapy
-
From allergen molecules to allergy management: can molecular diagnosis improve allergen immunotherapy efficacy?
-
Immunotherapy-induced neutralising antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy
-
Profiling Allergenic Proteins in Allergen Extracts of the Newly Developed Timothy Grass Allergen Specific IgE Assay on a Fully Automated Chemiluminescence Immunoassay Platform – Autolumo® A2000 Plus
-
The clinical value of allergen detection panel in Guangzhou, southern China: A big data study based on allergen detection in the past 7 years
Show more Sessions (153)Show Less-